Stanley B. Gosliner

Statistics

Publications

Citations

347

H-Index

Active since

2020

Affiliations

Parker Institute for Cancer Immunotherapy(Current)

University of California, Los Angeles

City of Hope

Beckman Research Institute

Stanley B. Gosliner is an author at Parker Institute for Cancer Immunotherapy specializing in immunology, chimeric antigen receptor t-cell therapy, and oncology.

ORCID

Publications per year

2020–2022

Publications

Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma

Eugenia Zah, Eunwoo Nam, Vinya Bhuvan et al. · Nature Communications · 2020 · 224 citations · Full text

Medicine, Immunology, Oncology +17

CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

Sarah Larson, Christopher M. Walthers, Brenda Ji et al. · Cancer Discovery · 2022 · 101 citations · Full text

Life Sciences, Immunology, Oncology +17

Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma

Eugenia Zah, Eunwoo Nam, Vinya Bhuvan et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 22 citations · Full text

Medicine, Immunology, Oncology +17

1–3 of 3